Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00856648 · ClinicalTrials.gov registry record
SmartPill Monitoring for Assessment of GI Function in SCI
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 40
- Enrollment target
NCT00856648 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 40 participants.
The verdict
NCT00856648 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The present study aims to evaluate the relationship between the level of SCI and the impairment of Colonic transit time (CTT) and Total transit time (TTT) by using the SmartPill device. The SmartPill, an FDA approved device, is a wireless capsule that is ingested and transmits values for GI pH, temperature, and pressure as it travels throughout the digestive system. The SmartPill can also be used to assess CTT and TTT. In comparing values for CTT, TTT, pH, temperature, and pressure in SCI patients to healthy, able-bodied controls, the SmartPill device may provide valuable insight into the pathophysiological implications of SCI on GI function. This information may allow medical professionals to provide more effective plans of care for this population, subsequentially enhancing quality and quantity of life. The SmartPill device may also provide a less invasive alternative to assessing these variables, compared to traditional modalities.
Interventions
- DEVICE SmartPill ingestion and monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00856648
The ClinicalTrials.gov registry entry for NCT00856648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmartPill ingestion and monitoring is the first listed.
NCT00856648 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00856648 about?
NCT00856648 is a clinical study titled "SmartPill Monitoring for Assessment of GI Function in SCI". The present study aims to evaluate the relationship between the level of SCI and the impairment of Colonic transit time (CTT) and Total transit time (TTT) by using the SmartPill device. The SmartPill, an FDA approved device, is a wireless capsule that is ingested and transmits values for GI pH, temp...
What is the current status of trial NCT00856648?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2009-04. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00856648?
The interventions under investigation include: SmartPill ingestion and monitoring (DEVICE).
Who is sponsoring clinical trial NCT00856648?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.